Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP972235priorityCriticalpatent/ECSP972235A/en
Publication of ECSP972235ApublicationCriticalpatent/ECSP972235A/en
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Abstract
Esta invención se refiere a nuevos compuestos farmacéuticamente aceptables de fórmula (gráfico) en la que a, b y R1 a R6 son como se han definido en la memoria. Estos compuestos presentan actividad dopaminérgica central y son útiles en el tratamiento de trastornos deol sistema nervioso central.This invention relates to novel pharmaceutically acceptable compounds of formula (graph) in which a, b and R1 to R6 are as defined in the specification. These compounds exhibit central dopaminergic activity and are useful in the treatment of disorders of the central nervous system.
ECSP9722351997-08-251997-08-25
SPYROCYCLIC LEAGUES OF A DOPAMINE RECEPTOR SUBTYPE
ECSP972235A
(en)